SEC Form 4 · accession 0001127602-18-032337
MERIDIAN BIOSCIENCE INC · VIVO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John McIlwraith
Director
Period of report
Nov 5, 2018
Accepted (ET)
Nov 7, 2018 · 7:53 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000794172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 5, 2018 | M | 2,000 | $12.80 | A | 8,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy)F1 | $12.80 | Nov 5, 2018 | M | 2,000 | D | — | Jan 25, 2027 | Common Stock | 2,000 | 10,000 | D |
Explanation of responses
- F1These options became fully vested in January 2018.